Literature DB >> 279976

Absorption of bacampicillin and ampicillin and penetration into body fluids (skin blister fluid, saliva, tears) in healthy volunteers.

C Simon, V Malerczyk, M Klaus.   

Abstract

Equimolar doses of bacampicillin, which is rapidly converted to ampicillin in the body by hydrolysis, and ampicillin were administered orally, in the case of ampicillin also by intravenous injection, to 10 healthy subjects (cross-over study). Comparison of the areas under the serum concentrations curves after intravenous and oral administration showed that bacampillin was absorbed to 95% and orally given ampicillin to 35%. The mean peak serum levels (Cmax) after 0.8 g of oral bacampicillin were higher (15.9 microgram/ml) and appeared earlier (tmax 60 min) than after 0.556 g of oral ampicillin (3.2 microgram/ml, tmax 150 min). One and three hours after oral administration skin blister fluid contained four times more ampicillin after doses of bacampicillin than after oral ampicillin. One hour after intravenous injection of ampicillin the skin blister concentrations were 20 times higher than after oral administration of this antibiotic and three to four times higher than after oral administration of bacampicillin. The levels in saliva and tears were also determined and showed similar relationships. Since higher peaks serum levels resulted in higher and longer lasting concentrations in the extravascular space, bacampicillin is to be preferred for oral therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 279976

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  10 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 2.  Prodrugs. Do they have advantages in clinical practice?

Authors:  V J Stella; W N Charman; V H Naringrekar
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

3.  Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.

Authors:  M T Borin; G S Hughes; C R Spillers; R K Patel
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 4.  Pharmacokinetics of bacampicillin tablets in adults.

Authors:  W A Craig
Journal:  Bull N Y Acad Med       Date:  1983-06

5.  Dynamics of ocular surface pH.

Authors:  W H Coles; P A Jaros
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

6.  Comparison of skin blisters and implanted cotton threads for the evaluation of antibiotic tissue concentrations.

Authors:  B Hoffstedt; M Walder; A Forsgren
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

7.  Human pharmacokinetics and disposition of sarmoxicillin, a lipophilic amoxicillin prodrug.

Authors:  R D Smyth; M Pfeffer; D R Van Harken; A Cohen; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

Review 8.  Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.

Authors:  T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

9.  Ampicillin concentrations in middle ear effusions in acute otitis media after administration of bacampicillin.

Authors:  S Virtanen; E A Lahikainen
Journal:  Infection       Date:  1979       Impact factor: 3.553

10.  Penetration of ampicillin into urethral and cervical secretions after oral administration of bacampicillin.

Authors:  L O Kallings; G Eriksson; S Hoffner; U B Linse
Journal:  Infection       Date:  1979       Impact factor: 3.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.